Global market forecast of biosimilars 2023-2033
This statistic displays a forecast for the global biosimilars market up to 20233. In 2023, the global biosimilars market was estimated at some 30 billion U.S. dollars.
Global biosimilars market forecast from 2023 to 2033 (in billion U.S. dollars)
* For commercial use only
Basic Account
For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
- Free Statistics
Based on your interests
Starter Account
For single users
$199 USD
per month, billed annually
1
- Free Statistics
- Premium Statistics
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
For teams of up to 5 people
$959 USD
per month, billed annually
1
- Free + Premium Statistics
- Reports
- Market Insights
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
Other statistics that may interest you Generics and biosimilars
Global overview
5
- Premium Statistic Pharmaceutical market: worldwide revenue 2001-2023
- Basic Statistic Generic drugs market size worldwide 2023-2033
- Premium Statistic Global market forecast of biosimilars 2023-2033
- Basic Statistic Worldwide Rx drug revenue - market at risk from patent expiration 2024-2030
- Basic Statistic Market share of generics in European countries 2022
Top companies
5
- Premium Statistic Revenues of leading global generics manufacturers 2023
- Premium Statistic Teva Pharmaceutical Industries' generic revenues by region 2016-2023
- Premium Statistic Sandoz net sales 2014-2023 by segment
- Premium Statistic Viatris revenue 2019-2023
- Premium Statistic Sun Pharma's income FY 2010-2024
U.S. market
6
- Premium Statistic Number of ANDAs received in U.S. 2009-2023
- Premium Statistic U.S. brand and generic prescription drug spending 2020-2023
- Premium Statistic Branded vs. generic U.S. drug prescriptions dispensed 2020-2023
- Premium Statistic Generic drugs revenue top corporations in the U.S. 2023
- Premium Statistic Generics market share of top corporations in the U.S. 2023
- Premium Statistic Top pharma products by prescriptions U.S. 2022
Patent expiration
3
Savings
7
- Premium Statistic Savings through generic drug usage in the U.S. 2008-2023
- Premium Statistic Total savings of top generic drugs in U.S. 2023
- Premium Statistic Saving of U.S. costs through generic pharmaceuticals by condition 2023
- Basic Statistic Savings through generic drug usage in the U.S., by age group 2023
- Basic Statistic Savings through generic drug usage in the U.S., by payer 2023
- Basic Statistic Percentage savings through generic drug usage in the U.S. by payer 2023
- Basic Statistic Savings through generic drug usage in the U.S., by age group share 2023
Biosimilars
7
- Premium Statistic Global market share of biosimilars by region 2023
- Basic Statistic Number of biosimilars approved by FDA 2015-2023
- Basic Statistic New U.S. biosimilar launches of top products 2024-2029
- Premium Statistic Adalimumab wholesale acquisition cost in the U.S. 2024
- Premium Statistic Share of adalimumab sales Humira vs. biosimilars U.S. 2024
- Premium Statistic Share of filgrastim sales attributable to Neupogen or biosimilars US 2015-2024
- Premium Statistic Share of insuline glargine sales Lantus vs. biosimilar US 2015-2024
Further related statistics
10
- Size of U.S. hospices by number of admissions 2012-2014
- Medicinal market growth worldwide including rebates 2009-2018
- Sanofi's total assets 2007-2023
- Merck & Co - expenditure on research and development 2006-2023
- Pfizer's revenues in the U.S. and abroad 2009-2023
- Unitedhealth Group total assets 2019-2023
- Medicaid long-term care expenditures in the U.S. 1990-2022,by type of service
- Employer firm revenue of residential care and nursing facilities by tax category 2021
- Cost savings through urgent care vs emergency department 2012
- Merck & Co total assets 2019-2023
Further Content: You might find this interesting as well
Statistics
- Size of U.S. hospices by number of admissions 2012-2014
- Medicinal market growth worldwide including rebates 2009-2018
- Sanofi's total assets 2007-2023
- Merck & Co - expenditure on research and development 2006-2023
- Pfizer's revenues in the U.S. and abroad 2009-2023
- Unitedhealth Group total assets 2019-2023
- Medicaid long-term care expenditures in the U.S. 1990-2022,by type of service
- Employer firm revenue of residential care and nursing facilities by tax category 2021
- Cost savings through urgent care vs emergency department 2012
- Merck & Co total assets 2019-2023
* For commercial use only
Basic Account
For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
- Free Statistics
Based on your interests
Starter Account
For single users
$199 USD
per month, billed annually
1
- Free Statistics
- Premium Statistics
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
For teams of up to 5 people
$959 USD
per month, billed annually
1
- Free + Premium Statistics
- Reports
- Market Insights
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
BioSpace. (June 17, 2024). Global biosimilars market forecast from 2023 to 2033 (in billion U.S. dollars) [Graph]. In Statista. Retrieved December 03, 2024, from https://www.statista.com/statistics/381902/biosimilars-global-market-forecast/
BioSpace. "Global biosimilars market forecast from 2023 to 2033 (in billion U.S. dollars)." Chart. June 17, 2024. Statista. Accessed December 03, 2024. https://www.statista.com/statistics/381902/biosimilars-global-market-forecast/
BioSpace. (2024). Global biosimilars market forecast from 2023 to 2033 (in billion U.S. dollars). Statista. Statista Inc.. Accessed: December 03, 2024. https://www.statista.com/statistics/381902/biosimilars-global-market-forecast/
BioSpace. "Global Biosimilars Market Forecast from 2023 to 2033 (in Billion U.S. Dollars)." Statista, Statista Inc., 17 Jun 2024, https://www.statista.com/statistics/381902/biosimilars-global-market-forecast/
BioSpace, Global biosimilars market forecast from 2023 to 2033 (in billion U.S. dollars) Statista, https://www.statista.com/statistics/381902/biosimilars-global-market-forecast/ (last visited December 03, 2024)
Global biosimilars market forecast from 2023 to 2033 (in billion U.S. dollars) [Graph], BioSpace, June 17, 2024. [Online]. Available: https://www.statista.com/statistics/381902/biosimilars-global-market-forecast/